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Abstract
Objectives:  To  longitudinally  assess  bone  mineral  content  (BMC),  bone  mineral  density  (BMD),
and whole-body  lean  mass  obtained  through  bone  densitometry  by  dual-energy  X-ray  absorp-
tiometry  (DXA)  in  preterm  newborns  (PTNs)  and  compare  them  with  full-term  newborns  (FTNs)
from  birth  to  6  months  of  corrected  postnatal  age.
Methods:  A  total  of  28  adequate  for  gestational  age  (AGA)  newborns  were  studied:  14  preterm
and 14  full-term  newborns.  DXA  was  used  to  determine  BMC,  BMD,  and  lean  mass  in  three
moments:  40  weeks  corrected  post-conceptual  age,  as  well  as  3  and  6  months  of  corrected
postnatal  age.  PTNs  had  gestational  age  ≤  32  weeks  at  birth  and  were  fed  their  mother’s  own
milk  or  milk  from  the  human  milk  bank.
Results:  All  infants  had  an  increase  in  BMC,  BMD,  and  lean  body  mass  values  during  the  study.
PTNs had  lower  BMC,  BMD,  and  lean  mass  at  40  weeks  of  corrected  post-conceptual  age  in  rela-
tion  to  FTNs  (p  <  0.001,  p  <  0.001,  p  =  0.047,  respectively).  However,  there  was  an  acceleration
in  the  mineralization  process  of  PTNs,  which  was  sufﬁcient  to  achieve  the  normal  values  of  FTNs
at  6  months  of  corrected  age.
Conclusions: This  study  suggests  that  bone  densitometry  by  dual-energy  X-ray  absorptiometry
is a  good  method  for  the  assessment  of  body  composition  parameters  at  baseline,  and  at  the
follow-up  of  these  PTNs.
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Densitometria  óssea  de  dupla  absorc¸ão  de  raio-X  (DXA)  em  crianc¸as  nascidas
pré-termo  comparada  com  seus  pares  a  termo  nos  primeiros  6  meses
Resumo
Objetivos:  Avaliar  longitudinalmente  o  conteúdo  mineral  ósseo  (CMO),  a  densidade  mineral
óssea (DMO)  e  a  massa  magra  do  corpo  inteiro  obtidos  através  da  densitometria  óssea  de  dupla
absorc¸ão  de  Raios-X  (DXA)  em  recém-nascidos  pré-termo  (RNPT)  e  comparar  com  seus  pares  a
termo  (RNT)  desde  o  nascimento  até  6  meses  de  idade  pós-natal  corrigida.
Métodos: Foram  estudados  28  recém-nascidos  adequados  para  a  idade  gestacional:  14  recém-
nascidos pré-termo  e  14  recém-nascidos  a  termo.  Utilizando-se  a  DXA,  foram  determinados  CMO,
DMO  e  massa  magra  em  três  momentos:  40  semanas  de  idade  pós-concepcional  corrigida,  3  e  6
meses  de  idade  pós-natal  corrigida.  Os  recém-nascidos  pré-termo  apresentavam  ao  nascimento
uma  idade  gestacional  igual  ou  inferior  a  32  semanas  e  receberam  leite  da  própria  mãe  ou  leite
humano  de  banco.
Resultados:  Todos  os  recém-nascidos  apresentaram  um  aumento  nos  valores  de  CMO,  DMO  e
massa  magra  durante  o  estudo.  Os  recém-nascidos  pré-termo  apresentaram  menor  CMO,  DMO
e  massa  magra,  com  40  semanas  de  idade  pós-concepcional  corrigida,  em  relac¸ão  aos  recém-
nascidos  a  termo  (p  <  0,001,  p  <  0,001,  e  p  =  0,047,  respectivamente).  Entretanto,  houve  uma
acelerac¸ão  no  processo  de  mineralizac¸ão  nos  pré-termos,  suﬁciente  para  atingirem  os  valores
normais  do  recém-nascidos  a  termo  aos  6  meses  de  idade  corrigida.
Conclusões:  Este  estudo  sugere  que  a  densitometria  óssea  de  dupla  absorc¸ão  de  Raios-X  cons-
titui um  bom  método  para  a  avaliac¸ão  dos  parâmetros  de  composic¸ão  corporal  no  início  e  no
seguimento  destes  recém-nascidos  pré-termo.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Metabolic  bone  disease  is  characterized  by  changes  in  skele-
tal mineralization  due  to  poor  bone  mineral  content  (BMC)
accrual. In  preterm  newborns  (PTNs),  the  BMC  is  inversely
proportional to  birth  weight  and  gestational  age;  decreased
BMC is  also  related  to  inadequate  intake  of  calcium  and
phosphorus in  extra-uterine  life.1--3
Risk  factors  related  to  inadequate  mineralization  are:
very-low birth  weight,  intrauterine  growth  restriction,  pro-
longed use  of  parenteral  nutrition,  use  of  diuretics  and
glucocorticoids, bronchopulmonary  dysplasia,  delay  in  intro-
duction of  food,  low  mineral  supply  in  the  diet,  and  long
immobilization periods.4--6 The  use  of  supplemented  human
milk is  able  to  provide  proper  growth  and  bone  mineraliza-
tion in  the  short  term.7
Metabolic  bone  disease  of  PTNs  has  no  characteristic
clinical presentation.  It  can  be  observed  with  longitudi-
nal growth  arrest,  maintenance  of  head  circumference,
and even  radiological  signs  similar  to  rickets,  with  sponta-
neous fractures  described  in  10%  of  PTNs  with  very-low  birth
weight.8
In  PTNs  with  mineral  deﬁciency,  some  biochemical  mark-
ers may  be  altered.  Hypophosphaturia  and  hypercalciuria
that precede  serum  alterations  (reduction  in  calcium  and
phosphorus, and  elevated  alkaline  phosphatase)  and  radio-
logical alterations  can  be  observed.5,9 Other  more  speciﬁc
serum or  urinary  markers,  such  as  bone-speciﬁc  alkaline
phosphatase (BAP),  deoxypyridinoline  (DPD),  osteocalcin,  C-
terminal telopeptide  of  type  I  collagen  (CTX),  and  C-type
natriuretic peptide  (CNP)  may  be  used  for  growth  and  bone
remodeling assessment.10--12
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aAdditionally,  bone  densitometry  by  dual-energy  X-ray
bsorptiometry (DXA)  has  been  considered  the  gold  standard
ethod to  assess  bone  mineralization  in  newborns,  showing
igh precision  and  accuracy.4,10,11,13--15
The  aim  of  this  study  was  to  evaluate  bone  mineraliza-
ion by  DXA  in  the  ﬁrst  6  months  of  corrected  age  in  PTNs
ompared with  FTNs.
ethods
his  was  a  longitudinal  study  involving  newborns  admitted
o the  Neonatal  Unit  of  the  Hospital  Universitário  da  Univer-
idade de  São  Paulo  (USP),  with  gestational  age  ≤  32  weeks,
ollowed from  July  of  2006  to  September  of  2008.  As  con-
rol group,  a  group  of  full-term  newborns  (FTNs)  born  in  the
ame period  were  selected.
Newborns  with  congenital  malformations,  chromosomal
isorders, or  genetic  disorders  were  excluded,  as  well  as
ewborns of  diabetic  mothers.  Newborn  small  or  large  for
estational age  were  also  excluded.  Informed  consent  was
btained from  all  parents  of  the  assessed  newborns.  The
tudy was  approved  by  the  Ethics  Committee  of  Hospital
niversitário da  USP.
During  this  period,  42  newborns  (17  PTNs  and  25  FTNs)
ere selected.  Fourteen  newborns  (three  PTNs  and  11  PTNs)
ere excluded  due  to:  failure  to  complete  follow-up  (ten),
iagnosis of  severe  heart  disease  (one)  malnutrition  (one),
ack of  informed  consent  (one),  and  inadequate  DXA  assess-
ent (one).  After  exclusions,  28  newborns  were  evaluated:
4 PTNs  (nine  males  and  ﬁve  females);  and  14  FTNs  (ten
ales and  four  females).  The  PTNs  had  a  mean  gestational
ge of  28.4  to  32.0  weeks  (mean  31.1)  and  FTNs,  of  38  to  41.8
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eeks  (mean  40.1).  Birth  weight  of  the  PTNs  ranged  from
,115 g  to  2,130  g  (mean  1,540  g),  and  in  FTNs,  from  2,900  g
o  3,700  g  (mean  3,260  g).  All  had  weight  between  the  10th
nd 90th  percentiles  of  the  reference  curve  of  Alexander
t al.16
ample  size  calculation
ccording  to  the  reference  values  of  BMC  for  PTNs  and  FTNs,
he estimated  variability  is  approximately  6.5  g  (SD  = 6.5  g)
t 40  weeks  of  corrected  age.2 Assuming  a  difference  in  BMC
etween PTNs  and  FTNs  is  found  at  6-months  of  follow-up  of
t least  7  g  (with  the  initial  difference  being  10  g  between
he two  groups),  an  improvement  of  at  least  30%  in  PTNs
hould be  expected,  with  an  80%  power  and  95%  conﬁdence.
ased on  this  calculation,  the  sample  required  to  perform
he study  would  be  14  patients  in  each  group.
Risk  factors  for  inadequate  mineralization  (pathologies
nd medications)  found  in  pre-term  infants  were  sepsis  with
ositive blood  cultures,  which  was  observed  in  28.5%;  necro-
izing enterocolitis  (Bell’s  criteria)  with  clinical  therapy,
hich was  seen  in  14.3%;  and  bronchopulmonary  dysplasia
requiring oxygen  therapy  for  28  days  or  more),  observed
n 35.7%.  Of  total  PTNs  with  bronchopulmonary  dysplasia,
hree received  hydrochlorothiazide  and  two,  furosemide.
leven received  parenteral  nutrition;  two  for  less  than  one
eek, and  nine  for  between  one  week  and  one  month,  with
2 days  as  the  mean  duration  of  parenteral  nutrition.
Enteral  feeding  was  introduced  on  the  ﬁrst  day  of  life.
uring hospitalization  in  the  neonatal  unit,  all  PTNs  received
uman milk,  both  their  own  mother’s  milk  and  milk  from
he University  Hospital  bank.  Only  four  of  the  seven  preterm
nfants with  birth  weight  <  1,500  g  received  human  milk  sup-
lemented with  an  additive  (FM85®)  in  pumped  breast  milk
r pasteurized  human  milk  and  administered  by  orogastric
ube or  cup.  The  remaining  three  PTNs  had  hypophospha-
uria (urinary  phosphorus  <  1  mg  kg−1 d−1)  and  therefore
eceived an  additional  supply  of  calcium  and  phosphorus  to
chieve a  supply  of  200  mg  of  calcium/kg  and  110  mg  phos-
horus/kg per  day.9 All  newborns  (preterm  and  full-term)
eceived enteral  supplementation  of  vitamin  D  at  a  dose  of
00 IU/day,  which  was  maintained  during  the  ﬁrst  two  years
f age.
After discharge,  the  children  were  assessed  monthly.  Dur-
ng the  study  period,  all  infants  were  fed  exclusively  human
ilk. Children  with  indication  for  additive  use  received  a
ombined solution  of  calcium  gluconate  and  dibasic  calcium
hosphate between  breast-feedings,  which  was  maintained
or the  ﬁrst  six  months  of  age  (age  corrected  for  the  PTNs
nd chronological  age  for  the  FTNs),  and  complementary
eeding was  not  introduced.
All  newborns  were  weighed  on  an  electronic  scale  (Baby
odel; Filizola  -  São  Paulo,  Brazil)  and  height  was  obtained
sing an  anthropometric  ruler  graduated  in  centimeters.
In  the  group  of  PTNs,  serum  calcium,  phosphorus,  and
lkaline phosphatase  measurements  were  performed  at  the
ges of  40  post-conceptual  weeks  and  6  months  of  corrected
ostnatal age.  Furthermore,  the  concentration  of  calcium
nd phosphorus  was  determined  in  6-hour  urine  samples
etween the  third  and  fourth  weeks  of  life  (uncorrected
ge).
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In  the  group  of  FTNs,  measurements  of  serum  calcium,
hosphorus, and  alkaline  phosphatase  were  performed  only
t  40  weeks  post-conceptual  age,  as  blood  collection  at  6
onths was  not  approved  by  the  Ethics  Committee.
Bone  densitometry  was  performed  at  the  Laboratory  for
one Metabolism  of  Rheumatology,  Faculdade  de  Medicina
a USP.  The  following  parameters  were  evaluated:  BMC,
one mineral  density  (BMD),  and  lean  mass  in  three  periods:
0 weeks  of  corrected  post-conceptual  age,  as  well  as  3  and
 months  of  corrected  postnatal  age.  BMC  reﬂects  the  total
mount of  material  (mineral  bone)  measured  by  absorp-
iometry, in  grams;  BMD  is  deﬁned  as  bone  mineral  content
ivided by  bone  area  in  grams  per  square  centimeter,  and
ean body  mass  is  fat-free  mass.
A  dual  X-ray  absorptiometry  (DXA)  apparatus  was  used
DXA: Discovery  A;  Hologic  Inc.  -  Bedford,  MA,  USA)  with  the
nfant Whole-Body  scanning  mode  (software  version  12.3.3;
ologic Inc.).
The software  used  is  considered  superior  to  pediatric
oftware for  the  analysis  of  bone  mineral,  accurately  val-
dated for  both  PTNs  and  FTNs.17 In  addition,  the  fan-beam
echnique, used  in  the  study,  makes  the  Discovery  A  scan-
er more  accurate  when  compared  to  the  prior  pencil-beam
echnique.18 The  study  by  Blake  et  al.  demonstrated  that
he Discovery  A  scanner  has  additional  advantages,  as  it
equires a  lower  radiation  dose  when  compared  to  the  pre-
iously used  Discovery  W  (Hologic  Inc.  -  Bedford,  MA,  USA)
nd QDR  4500  Hologic  Inc.  - Bedford,  MA,  USA)  models.  For
 newborn,  the  effective  radiation  dose  is  8.9  mSv  for  the
hole body,  and  it  is  7.5  mSv  for  a  child  aged  1  year.19
Examinations  were  performed  without  sedation  after
reastfeeding. The  coefﬁcient  of  variation  for  whole  body
MD was  0.004  g/cm2 (0.4%),  and  the  minimum  signiﬁcant
ifference for  newborns  evaluated  in  the  study  was  1.2%
95% conﬁdence  interval).  These  values  are  appropriate,  as
he literature  describes  coefﬁcient  values  ranging  from  0.8
o  2.2%.20
tatistical  analysis
tatistical  analysis  was  performed  using  the  Statistical  Anal-
sis System,  release  9.1.3  (SAS  Institute,  Cary,  NC,  USA),
nd analysis  of  variance  (ANOVA)  with  repeated  measure-
ents was  performed  in  the  PROC  MIXED  module  of  SAS  (SAS
nstitute, Cary,  NC,  USA).  Tukey  multiple  comparisons  were
erformed after  the  ANOVA,  which  allowed  for  detection  of
he differences.  To  assess  the  association  of  variables  with
he group,  Fisher’s  exact  test  was  used.  A  signiﬁcance  level
f 5%  was  adopted  in  all  analyses.
esults
 total  of  28  newborns  were  assessed:  14  PTNs  and  14  FTNs.
he gestational  age  of  the  PTNs  ranged  from  28.4  to  32.0
eeks (mean  31.1  weeks).  Birth  weight  was  1,115-2,130  g
mean  1,540  g)  and  2,900-3,700  g  (mean  3,260  g)  for  PTNs
nd FTNs,  respectively,  and  all  of  were  adequate  for  gesta-
ional age.  Fourteen  infants  (11  FTNs  and  three  PTNs)  were
xcluded, as  they  did  not  complete  the  assessment,  and  they
howed similar  weight,  gestational  age,  and  gender  to  the
nfants included  in  the  study  (p  >  0.05)  (Table  1).
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Table  1  Comparison  of  birth  weight,  gestational  age,  and  gender  of  children  excluded  from  and  included  in  the  study.
NB  Preterm  Full-Term  p
Mean  SD  n  Mean  SD  n
Birth  weight  (kg)
Excluded 1.65 0.24 3 3.24  0.27  11
0.658Included  1.54 0.30 14 3.26  0.24  14
GA  (weeks)
Excluded  30.76  0.22  3  39.71  0.99  11
0.366Included  31.15  1.41  14  40.10  0.99  14
Gender  (male)  n  (%)
Excluded 2  (66.7)  3  6  (54.5)  11
0.495a
Included  9  (64.3)  14  10  (71.4)  14
ANOVA result.
a chi-squared test result.
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Figure  1  Evolution  of  growth  with  Z-scores  for  weight  and
length of  preterm  infants  in  relation  to  their  full-term  peers  atANOVA,  analysis of variance; SD, standard deviation; GA, gestatio
Fig.  1  shows  the  z-score  for  weight  (kg)  and  height  (cm),
and Fig.  2  shows  BMC  (g),  BMD  (g/cm2),  and  lean  mass  (g)  of
PTNs and  FTNs  throughout  the  follow-up  period,  at  40  weeks
of post-conceptual  age,  and  at  3  and  6  months  of  corrected
gestational age.  At  all  times,  differences  were  observed
between the  PTNs  and  FTNs,  in  both  Z-score  measures  of
weight and  height,  as  well  as  BMC,  BMD,  and  lean  mass.
The comparison  between  the  PTNs  and  FTNs  showed  that
at the  initial  assessment  (40  weeks  of  post-conceptual  age),
PTNs had  lower  values  when  compared  to  FTNs  regarding
weight, Z-scores  for  weight  and  height,  BMC,  BMD,  and  lean
mass (p  <  0.05)  (Table  2).  However,  these  differences  disap-
peared at  the  6-month  evaluation  of  postnatal  age,  when
all parameters  showed  similar  means  between  the  PTNs  and
FTNs (p  >  0.05)  (Table  2).
Serum  biochemical  parameters  did  not  differ  between
PTNs and  FTNs,  except  alkaline  phosphatase,  which  was  sta-
tistically higher  in  PTNs  in  relation  to  the  FTNs  (Table  2).
Only two  patients,  both  preterm,  had  alkaline  phos-
phatase levels  >  1,200  IU/L,  which  is  considered  suggestive
of metabolic  bone  disease.
Among  the  PTNs,  three  (21.4%)  had  results  of  urine  tests
suggestive of  phosphorus  deﬁciency  syndrome  (urinary  cal-
cium >  4  mg/kg  per  day,  and  urinary  phosphorus  <  1  mg/kg
per day).  For  this  reason,  the  use  of  the  oral  solution  of  cal-
cium and  phosphorus  was  indicated,  which  was  maintained
until the  corrected  age  of  6  months.
In  addition  to  this  solution  with  calcium  and  phosphorus
oral supplementation,  human  milk  additive  was  used  in  four
PTNs,  totaling  50%  of  preterm  infants  requiring  human  milk
supplementation.
Discussion
In  Brazil,  this  was  the  ﬁrst  study  conducted  on  the  evolu-
tion of  body  composition  of  PTNs  and  FTNs  fed  human  milk,
assessed by  DXA  after  discharge.
Bone  mineralization  of  PTNs  is  frequently  addressed  in
the literature,  and  DXA  has  become  the  method  of  choice
for assessing  body  composition  of  newborns.21--24
40 weeks,  3  months,  and  6  months  of  corrected  age.
No.  of  sample:  40  weeks  (preterm  and  full-term)  =  14;  3  months
(preterm and  full-term)  =  12;  6  months  (preterm  and  full-
term) =  13.
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Table  2  Measurements  of  weight,  z-score  for  weight  and  length,  bone  mineral  content  (BMC),  bone  mineral  density  (BMD),
lean  mass,  calcium,  phosphorus,  and  alkaline  phosphatase  in  preterm  newborns  and  full-term  newborns  at  40  weeks  corrected
post-conceptual  age,  as  well  as  3  and  6  months  of  corrected  postnatal  age.
Preterm
n  =  14
Full-Term
n  =  14
p
Weight  (kg)
Initial 2.25  ±  0.21  3.26  ±  0.24  <  0.001
3 months 5.03  ±  0.60 6.08  ±  0.59  0.001
6 months 7.29  ±  0.80 7.55  ±  0.81 0.701
Z-score
Initial -2.58  ±  0.54 -0.16  ±  0.40 <  0.001
Weight
3 months  -1.58  ±  1.14  -0.32  ±  0.60  0.001
6 months  -0.49  ±  0.90  -0.25  ±  0.70  0.931
Z-score
Initial -2.22  ±  1.63  -0.25  ±  0.61  <  0.001
Length
3 months -2.06  ±  1.12 -0.06  ±  0.51  <  0.001
6 months -0.59  ±  1.27 0.19  ±  1.01 0.426
BMC (g)
Initial  31.80  ±  6.10  60.76  ±  7.32  <  0.001
3 months  84.57  ±  14.23  117.66  ±  14.10  <  0.001
6 months  137.14  ±  22.46  152.86  ±  20.92  0.054
BMD (g/cm2)
Initial  0.13  ±  0.02  0.19  ±  0.01  <  0.001
3 months  0.19  ±  0.02  0.21  ±  0.01  0.008
6 months  0.22  ±  0.02  0.23  ±  0.02  0.618
Lean mass  (g)
Initial 2,377.52  ±  267.75  3,084.82  ±  227.47  0.047
3 months  4,084.72  ±  1,030.99  4,863.21  ±  587.74  0.035
6 months  5,750.13  ±  765.11  5,745.88  ±  726.52  1.000
Calcium (mg/dL)
Initial 9.86  ±  0.53  10.25  ±  0.49  0.076
6 months  10.54  ±  0.41  NA
Phosphorus  (mg/dL)
Initial 6.50  ±  0.78  5.85  ±  1.12  0.085
6 months  6.13  ±  0.54  NA
Alkaline  phosphatase  (IU/L)
Initial 959.50  ±  561.64  392.85  ±  101.47  <  0.001
6 months  743.42  ±  327.80  NA
Data shown as mean ± SD.
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The  present  study  demonstrated,  through  evaluation  by
XA, that  PTNs  reach  BMC  and  BMD  similar  to  those  of  FTNs
fter 6  months  of  corrected  age.
The  study  sample  consisted  of  14  PTNs,  of  whom  50%  had
ery-low birth  weight.  Nutritional  support  was  required  for
roper growth  of  these  infants  weighing  less  than  1,500  g,
ith a  high  supply  of  calcium,  phosphorus,  and  protein,  as
hese infants  show  an  accelerated  bone-remodeling  rate.
t birth,  these  PTNs  had  lower  BMC  and  BMD  in  relation  to
TNs, which  persisted  until  6  months  of  corrected  age.  This
bservation is  in  agreement  with  the  literature,  where  there
e
p
dal age; NA, not assessed.
re  reports  of  PTNs  who,  although  receiving  human  milk  and
upplementation, did  not  signiﬁcantly  improve  bone  miner-
lization until  they  reached  full  term.4
This  study  demonstrated,  through  analysis  by  DXA,  that
he process  of  bone  mineralization  showed  a  signiﬁcant
cceleration in  PTNs,  but  was  still  far  from  that  observed  in
TNs up  to  6  months  of  corrected  age,  suggesting  that  min-
ral supplementation  should  be  carried  out  for  a  prolonged
eriod in  very-low  birth  weight  newborns.
In  PTNs,  calcium  and  phosphorus  urinary  concentrations
epend on  a  complex  interaction  between  ingestion,
DXA  in  preterm  newborns  
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Figure  2  Evolution  of  bone  mineral  content  (g),  bone  min-
eral density  (g/cm2),  and  lean  mass  (g),  in  preterm  newborns
in relation  to  their  full-term  peers  evaluated  by  DXA.
No.  of  sample:  40  weeks  (preterm  and  full-term)  =  14;  3  months
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9. Catache M, Leone CR. Role of plasma and urinary calcium(preterm and  full-term)  =  12;  6  months  (preterm  and  full-
term) =  13.
absorption,  and  renal  function  in  these  infants.  Some
authors recommend  a  urinalysis  of  these  ions  as  a  method
to determine  the  need  for  supplementation,  aiming  to
improve BMC  and  reduce  the  incidence  of  metabolic  bone
disease. However,  these  analyses  do  not  appear  to  substi-
tute the  direct  measurement  of  BMC  and  BMD.9,25 In  fact,
the present  study  demonstrated  that  the  BMC  and  BMD  were
signiﬁcantly lower  in  PTNs  when  compared  to  FTNs,  even  in
infants with  normal  urinary  and  serum  measurements.
Among  serum  markers  of  metabolic  bone  disease,  the
most widely  used  is  alkaline  phosphatase.  However,  the
cutoff value  for  osteopenia  deﬁnition  varies  widely  in  the
literature, between  300  and  1,200  IU/L.  In  this  sense,
Figueras-Aloy et  al.  evaluated  alkaline  phosphatase  and  BMD561
n  336  PTNs  and  considered  metabolic  bone  disease  when
oth variables  were  altered  (alkaline  phosphatase  >  500  IU/L
nd BMD  <  0.068  g/cm2)  at  hospital  discharge.26
Although  metabolic  bone  disease  of  prematurity  is  a
elf-limiting process,  the  rapid  recovery  of  BMC  (catch  up)
as many  advantages:  better  growth  in  height  and  head
ircumference, prevention  of  fractures,  and  reduction  of
steopenia in  adulthood.27
Lean  mass  also  normalized  in  PTNs  at  6  months  of  cor-
ected postnatal  age,  a  ﬁnding  similar  to  that  reported  by
ooke et  al.,  albeit  in  children  assessed  at  12  months  of
orrected age.28 These  authors  found  that  lean  mass  was
ower in  PTNs  when  corrected  for  age.  However,  when  cor-
ected for  weight,  PTNs  had  lean  mass  values  similar  to  the
eference values  for  the  FTNs.
In  conclusion,  the  present  study  showed  that  PTNs
ecover BMD,  BMC,  and  lean  body  mass  at  6  months  of  cor-
ected age,  and  suggests  that  bone  densitometry  is  a  good
ethod for  the  assessment  of  these  parameters  at  the  initial
ssessment and  especially  at  follow-up  of  these  infants.
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